Table 2.
Non-cachexia (n = 50) | Early-cachexia (n = 40) | Late-cachexia (n = 28) | |
---|---|---|---|
Ages (years) | 63.5 ± 11.8 | 62.1 ± 10.6 | 59.7 ± 11.3 |
Female no. (%) | 22 (44.4%) | 18 (45%) | 13 (46.4%) |
BMI (kg/m2) | 23.9 ± 3.5 | 20.2 ± 3.1* | 18.3 ± 3.4*, # |
Serum albumin (g/l) | 38.6 ± 4.4 | 33.7 ± 3.8* | 30.1 ± 3.1*, # |
Serum triglyceride (mmol/l) | 1.3 ± 0.6 | 1.6 ± 0.9 | 1.4 ± 0.6 |
Serum FFA (mmol/l) | 0.32 ± 0.18 | 0.55 ± 0.25* | 0.41 ± 0.25 # |
Serum IL-6 (pg/ml) | 4.6 ± 2.7 | 7.2 ± 4.3* | 13.3 ± 7.4*, # |
Serum TNF-α (pg/ml) | 6.8 ± 4.4 | 10.2 ± 5.0 | 16.7 ± 6.7*, # |
*P < 0.05 (early stage cachexia VS. non-cachexia; or late stage cachexia VS. non-cachexia;); #P < 0.05 (late stage cachexia VS. early stage cachexia)